Quick Answer
Design Therapeutics, Inc. reported Net Income of -$69.79 million for fiscal year 2025.
Design Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$69.79M | -40.7% |
| 2024 | -$49.59M | +25.8% |
| 2023 | -$66.86M | -5.6% |
| 2022 | -$63.31M | -78.2% |
| 2021 | -$35.53M | -329.1% |
| 2020 | -$8.28M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.00M | -30.4% | +10.9% |
| June 30, 2025 | -$19.08M | -61.8% | -7.7% |
| March 31, 2025 | -$17.71M | -59.5% | -35.9% |
| September 30, 2024 | -$13.04M | +17.4% | -10.6% |
| June 30, 2024 | -$11.79M | +40.8% | -6.2% |
| March 31, 2024 | -$11.11M | +42.4% | +29.7% |
| September 30, 2023 | -$15.79M | +10.8% | +20.8% |
| June 30, 2023 | -$19.94M | -32.9% | -3.3% |
- Design Therapeutics, Inc. showed a decrease of -40.7% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Design Therapeutics, Inc.’s net income has declined by 742.9% (from -$8.28 million to -$69.79 million).
- The most recent figure is from Design Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: